Skip to content
HowShorted

Accelerate Diagnostics, Inc short interest in 2021

In 2021, Accelerate Diagnostics, Inc's disclosed short interest ran from 23.44% of shares outstanding on 15 Jan 2021 to 10.14% on 31 Dec 2021, a change of -13.30 percentage points. The year's high was 23.44% on 15 Jan 2021 and its low 10.14% on 31 Dec 2021, averaging 13.80% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 67.48 days on 13 Aug 2021. Full history: Accelerate Diagnostics, Inc.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025

Aggregate net short position time series for Accelerate Diagnostics, Inc in 2021

2021 in figures

Start of year
23.44% (15 Jan 2021)
End of year
10.14% (31 Dec 2021)
Change
-13.30 pp
High
23.44% (15 Jan 2021)
Low
10.14% (31 Dec 2021)
Average
13.80%
Highest days to cover
67.48 (13 Aug 2021)
SEC filings marked
8

Every report in 2021

Accelerate Diagnostics, Inc short interest in 2021
SettlementShort interestDays to coverFilings since previous
15 Jan 202123.44%52.42results (8-K)
29 Jan 202118.77%6.27
12 Feb 202116.80%12.48
26 Feb 202115.37%27.21results (8-K)
15 Mar 202115.53%33.3610-K filed
31 Mar 202115.42%45.56
15 Apr 202115.24%51.57
30 Apr 202115.20%55.70
14 May 202113.04%42.72results (8-K), 10-Q filed
28 May 202113.49%66.70
15 Jun 202112.98%38.41
30 Jun 202112.72%35.23
15 Jul 202112.84%62.54
30 Jul 202113.18%65.56
13 Aug 202113.10%67.4810-Q filed
31 Aug 202112.84%37.82
15 Sep 202112.54%62.30
30 Sep 202112.12%19.86
15 Oct 202112.20%16.35
29 Oct 202111.66%26.54
15 Nov 202110.93%16.37results (8-K), 10-Q filed
30 Nov 202110.92%11.39
15 Dec 202110.63%14.50
31 Dec 202110.14%16.62

See also: Accelerate Diagnostics, Inc's full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.